vs
Side-by-side financial comparison of GREENPOWER MOTOR Co INC. (GP) and LENZ Therapeutics, Inc. (LENZ). Click either name above to swap in a different company.
LENZ Therapeutics, Inc. is the larger business by last-quarter revenue ($12.5M vs $7.2M, roughly 1.7× GREENPOWER MOTOR Co INC.). GREENPOWER MOTOR Co INC. runs the higher net margin — -65.6% vs -133.6%, a 68.0% gap on every dollar of revenue.
GreenPower Motor Company Inc. is a Canadian electric bus manufacturer and distributor in North America. The company fabricates multiple zero-emission models, including transit buses, school buses, and double decker buses. GreenPower headquarters are in Vancouver, British Columbia, with a sales office in Rancho Cucamonga, California; an assembly facility in Porterville, California; and a production facility in South Charleston, West Virginia. Its stock is traded on Nasdaq the United States.
LENZ Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing novel ophthalmic therapies. Its lead product candidates address presbyopia, the age-related loss of near vision, catering to global patient groups with unmet medical needs in the eye care sector.
GP vs LENZ — Head-to-Head
Income Statement — Q3 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $7.2M | $12.5M |
| Net Profit | $-4.7M | $-16.7M |
| Gross Margin | 14.6% | — |
| Operating Margin | — | -151.1% |
| Net Margin | -65.6% | -133.6% |
| Revenue YoY | -11.5% | — |
| Net Profit YoY | -2.1% | -63.5% |
| EPS (diluted) | $-0.17 | $-0.59 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | — | $12.5M | ||
| Q2 25 | — | $5.0M | ||
| Q4 24 | $7.2M | — | ||
| Q3 24 | $5.3M | $0 | ||
| Q2 24 | $3.0M | $0 | ||
| Q4 23 | $8.2M | — | ||
| Q3 23 | $8.4M | — | ||
| Q2 23 | $17.6M | — |
| Q3 25 | — | $-16.7M | ||
| Q2 25 | — | $-14.9M | ||
| Q4 24 | $-4.7M | — | ||
| Q3 24 | $-4.7M | $-10.2M | ||
| Q2 24 | $-5.4M | $-10.3M | ||
| Q4 23 | $-4.6M | — | ||
| Q3 23 | $-4.3M | — | ||
| Q2 23 | $-2.8M | — |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q4 24 | 14.6% | — | ||
| Q3 24 | 8.6% | — | ||
| Q2 24 | 7.4% | — | ||
| Q4 23 | 16.6% | — | ||
| Q3 23 | 14.6% | — | ||
| Q2 23 | 15.9% | — |
| Q3 25 | — | -151.1% | ||
| Q2 25 | — | -337.1% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
| Q3 25 | — | -133.6% | ||
| Q2 25 | — | -298.2% | ||
| Q4 24 | -65.6% | — | ||
| Q3 24 | -87.9% | — | ||
| Q2 24 | -179.8% | — | ||
| Q4 23 | -56.9% | — | ||
| Q3 23 | -50.4% | — | ||
| Q2 23 | -16.0% | — |
| Q3 25 | — | $-0.59 | ||
| Q2 25 | — | $-0.53 | ||
| Q4 24 | $-0.17 | — | ||
| Q3 24 | $-0.18 | $-0.38 | ||
| Q2 24 | $-0.21 | $-0.40 | ||
| Q4 23 | $-0.19 | — | ||
| Q3 23 | $-0.17 | — | ||
| Q2 23 | $-0.11 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $621.1K | $25.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.1M | $193.9M |
| Total Assets | $37.4M | $210.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $25.4M | ||
| Q2 25 | — | $37.6M | ||
| Q4 24 | $621.1K | — | ||
| Q3 24 | $116.9K | $41.0M | ||
| Q2 24 | $528.3K | $84.0M | ||
| Q4 23 | $4.0M | — | ||
| Q3 23 | $2.0M | — | ||
| Q2 23 | $1.5M | — |
| Q3 25 | — | $193.9M | ||
| Q2 25 | — | $206.4M | ||
| Q4 24 | $2.1M | — | ||
| Q3 24 | $4.2M | $215.3M | ||
| Q2 24 | $8.6M | $192.9M | ||
| Q4 23 | $18.1M | — | ||
| Q3 23 | $22.3M | — | ||
| Q2 23 | $26.2M | — |
| Q3 25 | — | $210.7M | ||
| Q2 25 | — | $217.3M | ||
| Q4 24 | $37.4M | — | ||
| Q3 24 | $39.4M | $224.0M | ||
| Q2 24 | $43.5M | $202.6M | ||
| Q4 23 | $50.2M | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.1M | $-8.6M |
| Free Cash FlowOCF − Capex | — | $-9.0M |
| FCF MarginFCF / Revenue | — | -72.2% |
| Capex IntensityCapex / Revenue | — | 3.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-47.5M |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $-8.6M | ||
| Q2 25 | — | $-11.5M | ||
| Q4 24 | $-1.1M | — | ||
| Q3 24 | $-1.3M | $-10.6M | ||
| Q2 24 | $-3.2M | $-15.8M | ||
| Q4 23 | $1.4M | — | ||
| Q3 23 | $-5.4M | — | ||
| Q2 23 | $7.8M | — |
| Q3 25 | — | $-9.0M | ||
| Q2 25 | — | $-11.7M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-10.8M | ||
| Q2 24 | — | $-15.9M | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
| Q3 25 | — | -72.2% | ||
| Q2 25 | — | -235.0% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
| Q3 25 | — | 3.5% | ||
| Q2 25 | — | 4.8% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
